참고문헌
- Meier P, Seitz HK. Age, alcohol metabolism and liver disease. Curr Opin Clin Nutr Metab Care 2008;11:21-6. https://doi.org/10.1097/MCO.0b013e3282f30564
- Caputo F, Vignoli T, Leggio L, Addolorato G, Zoli G, Bernardi M. Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options. Exp Gerontol 2012;47:411-6. https://doi.org/10.1016/j.exger.2012.03.019
- Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol 2014;11:639-54. https://doi.org/10.1038/nrcardio.2014.118
- Csengeri D, Sprunker NA, Di Castelnuovo A, et al. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes. Eur Heart J 2021;42:1170-7. https://doi.org/10.1093/eurheartj/ehaa953
- Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol 2014;64:281-9. https://doi.org/10.1016/j.jacc.2014.03.048
- Yang JH, Jeong JA, Kweon SS, et al. Causal association between alcohol consumption and atrial fibrillation: a mendelian randomization study. Korean Circ J 2022;52:220-30. https://doi.org/10.4070/kcj.2021.0269
- Lawlor DA. Commentary: two-sample Mendelian randomization: opportunities and challenges. Int J Epidemiol 2016;45:908-15. https://doi.org/10.1093/ije/dyw127
- Jeon C, Lee JY, Lee SJ, Jung KJ, Kimm H, Jee SH. Bilirubin and risk of ischemic heart disease in Korea: a two-sample Mendelian randomization study. Epidemiol Health 2019;41:e2019034-0.
- Lee SH, Lee JY, Kim GH, et al. Two-sample mendelian randomization study of lipid levels and ischemic heart disease. Korean Circ J 2020;50:940-8. https://doi.org/10.4070/kcj.2020.0131
- Drummond C, Hillyard M, Leonhardt M, et al. Comparison of European clinical guidelines on the management of alcohol use disorders. Eur Addict Res 2021;27:227-36. https://doi.org/10.1159/000512112